n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with phosphoramidon in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (phosphoramidon) | Trials (phosphoramidon) | Recent Studies (post-2010) (phosphoramidon) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 781 | 12 | 33 |
| Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | phosphoramidon (IC50) |
|---|---|---|---|
| Thermolysin | Bacillus thermoproteolyticus | 0.033 | |
| Neprilysin | Rattus norvegicus (Norway rat) | 0.0578 | |
| Neprilysin | Oryctolagus cuniculus (rabbit) | 0.0028 | |
| Neprilysin | Homo sapiens (human) | 0.0405 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.615 | |
| Endothelin-converting enzyme 1 | Homo sapiens (human) | 1.0695 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akedo, H; Mukai, M; Shinkai, K; Yoshioka, K | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and phosphoramidon
| Article | Year |
|---|---|
Retraction of cultured endothelial cell monolayer by human breast cancer cells, MCF-7.
Topics: Breast Neoplasms; Cell Adhesion; Cell Communication; Cell Line; Culture Media, Conditioned; Endothelium, Vascular; Estradiol; Glycopeptides; Glycoproteins; Humans; Leucine; Medroxyprogesterone Acetate; Metalloendopeptidases; Microscopy, Phase-Contrast; Progesterone; Protease Inhibitors; Receptors, Progesterone; Tamoxifen; Tissue Inhibitor of Metalloproteinases; Trypsin; Tumor Cells, Cultured | 1993 |